Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Net Cash Flow: 2016-2024

Historic Net Cash Flow for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Dec 2024 value amounting to $209.6 million.

  • Crinetics Pharmaceuticals' Net Cash Flow rose 278.47% to $57.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$206.4 million, marking a year-over-year decrease of 218.28%. This contributed to the annual value of $209.6 million for FY2024, which is 843.34% up from last year.
  • Crinetics Pharmaceuticals' Net Cash Flow amounted to $209.6 million in FY2024, which was up 843.34% from $22.2 million recorded in FY2023.
  • In the past 5 years, Crinetics Pharmaceuticals' Net Cash Flow ranged from a high of $209.6 million in FY2024 and a low of -$167.2 million during FY2022.
  • Moreover, its 3-year median value for Net Cash Flow was $22.2 million (2023), whereas its average is $21.6 million.
  • In the last 5 years, Crinetics Pharmaceuticals' Net Cash Flow skyrocketed by 1,235.38% in 2020 and then crashed by 255.40% in 2022.
  • Yearly analysis of 5 years shows Crinetics Pharmaceuticals' Net Cash Flow stood at $52.8 million in 2020, then surged by 103.95% to $107.6 million in 2021, then slumped by 255.40% to -$167.2 million in 2022, then spiked by 113.29% to $22.2 million in 2023, then soared by 843.34% to $209.6 million in 2024.